TickerFacts.

TFA Therapeutics, Inc. (RAJAF): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

111.12M
Year ended 2025-12-31
+2.1%
3-year compound annual growth
2021-12-31: 100.0K2022-12-31: 104.42M2023-12-31: 111.12M2024-12-31: 111.12M2025-12-31: 111.12M111.12M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31111.12M0.0%2026-05-15, From 2025-01-01
2024-12-31111.12M0.0%2026-05-15, From 2024-01-01
2023-12-31111.12M+6.4%2026-05-15, From 2023-01-01
2022-12-31104.42Mn/m2025-09-23, From 2022-01-01
2021-12-31100.0Kn/a2025-09-23, From 2021-01-01